These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29205182)

  • 1. Association between gastroesophageal reflux disease and nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Saudi J Gastroenterol; 2017; 23(6):311-317. PubMed ID: 29205182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Saudi J Gastroenterol; 2018; 24(1):12-17. PubMed ID: 29451179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease increases the risk of gastroesophageal reflux disease: A systematic review and meta-analysis.
    Xue J; Xin H; Ren N; Zhou C; Yang J; Song L; Qin S
    Eur J Clin Invest; 2019 Sep; 49(9):e13158. PubMed ID: 31338830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease and Urolithiasis. A Systematic Review and Meta-Analysis.
    Wijarnpreecha K; Lou S; Panjawatanan P; Sanguankeo A; Pungpapong S; Lukens FJ; Ungprasert P
    J Gastrointestin Liver Dis; 2018 Dec; 27(4):427-432. PubMed ID: 30574625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Boonpheng B; Panjawatanan P; Sharma K; Ungprasert P; Pungpapong S; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):986-994. PubMed ID: 29787418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Lekuthai N; Thongprayoon C; Cheungpasitporn W; Ungprasert P
    Liver Int; 2017 Jun; 37(6):906-918. PubMed ID: 27891768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and gastroesophageal reflux disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Leelasinjaroen L; Ungprasert P
    J Postgrad Med; 2019; 65(4):207-211. PubMed ID: 31603078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Lou S; Watthanasuntorn K; Kroner PT; Cheungpasitporn W; Lukens FJ; Pungpapong S; Keaveny AP; Ungprasert P
    Eur J Gastroenterol Hepatol; 2020 May; 32(5):601-608. PubMed ID: 31567712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.
    Wijarnpreecha K; Boonpheng B; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):525-532. PubMed ID: 28866089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Prevalence of Gastroesophageal Reflux Disease Among Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
    Thongpiya J; Charoenngam N; Ponvilawan B; Yingchoncharoen P; Jaroenlapnopparat A; Ungprasert P
    Curr Rheumatol Rev; 2023; 19(4):496-503. PubMed ID: 37066776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    Wijarnpreecha K; Lou S; Panjawatanan P; Cheungpasitporn W; Pungpapong S; Lukens FJ; Ungprasert P
    Dig Liver Dis; 2018 Nov; 50(11):1166-1175. PubMed ID: 30292566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Panjawatanan P; Ungprasert P
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1802-1807. PubMed ID: 27029776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori and Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Panjawatanan P; Manatsathit W; Jaruvongvanich V; Ungprasert P
    J Clin Gastroenterol; 2018; 52(5):386-391. PubMed ID: 28098578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insomnia and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Panjawatanan P; Ungprasert P
    J Postgrad Med; 2017; 63(4):226-231. PubMed ID: 28862239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Kroner PT; Cheungpasitporn W; Ungprasert P
    Ann Gastroenterol; 2020; 33(6):661-666. PubMed ID: 33162743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol Consumption and the Risk of Gastroesophageal Reflux Disease: A Systematic Review and Meta-analysis.
    Pan J; Cen L; Chen W; Yu C; Li Y; Shen Z
    Alcohol Alcohol; 2019 Jan; 54(1):62-69. PubMed ID: 30184159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association between Periodontitis and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Cheungpasitporn W; Lukens FJ; Harnois DM; Pungpapong S; Ungprasert P
    J Gastrointestin Liver Dis; 2020 Jun; 29(2):211-217. PubMed ID: 32530988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Jaruvongvanich V; Sanguankeo A; Upala S
    Dig Dis Sci; 2016 Aug; 61(8):2389-2396. PubMed ID: 26993825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver disease.
    Taketani H; Sumida Y; Tanaka S; Imajo K; Yoneda M; Hyogo H; Ono M; Fujii H; Eguchi Y; Kanemasa K; Chayama K; Itoh Y; Yoshikawa T; Saibara T; Fujimoto K; Nakajima A;
    J Gastroenterol; 2014 Jul; 49(7):1163-74. PubMed ID: 23975270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inflammatory bowel disease treatment on the risk of nonalcoholic fatty liver disease: a meta-analysis.
    Lapumnuaypol K; Kanjanahattakij N; Pisarcik D; Thongprayoon C; Wijarnpreecha K; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):854-860. PubMed ID: 29697458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.